Mindfulness and other behavioral approaches.
Behavioral approach
Migraine
Mindfulness
Journal
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
ISSN: 1590-3478
Titre abrégé: Neurol Sci
Pays: Italy
ID NLM: 100959175
Informations de publication
Date de publication:
Sep 2022
Sep 2022
Historique:
received:
28
04
2022
accepted:
13
05
2022
pubmed:
28
5
2022
medline:
20
8
2022
entrez:
27
5
2022
Statut:
ppublish
Résumé
Mindfulness and other behavioral approaches have demonstrated efficacy in treatment of different kinds of chronic pain condition and migraine in particular. Such treatments are of particular utility in the treatment of chronic forms of migraine, also associated to medication overuse headache, in reason of the relevant comorbidity - and bidirectional relationship - between migraine, and two of the most common associated conditions, namely anxiety and depression. Second, in reason of the impact that such treatments may have on behavioral issues that might promote MOH maintenance, including external locus of control and self-efficacy. Although the specific mechanism of action of these approaches has not been clarified yet, the absence of side effects and their effectiveness make these options suitable for different categories of frail patients and also for patients during therapy with medication if we want to improve the efficacy of medications itself. The use of these approaches has to be encouraged for clinicians and for patients to treat at the best pain condition and migraine and to improve the efficacy of the new medication for migraine prevention.
Identifiants
pubmed: 35624359
doi: 10.1007/s10072-022-06155-z
pii: 10.1007/s10072-022-06155-z
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
5745-5747Informations de copyright
© 2022. Fondazione Società Italiana di Neurologia.
Références
Headache Classification Committee of the International Headache Society (IHS) (2018) The international classification of headache disorders, 3rd edition. Cephalalgia 38(1):1–211. https://doi.org/10.1177/0333102417738202
Raggi A, Grignani E, Leonardi M, Andrasik F, Sansone E, Grazzi L, D’Amico D (2018) Behavioral approaches for primary headaches: recent advances. Headache 58(6):913–925. https://doi.org/10.1111/head.13337
doi: 10.1111/head.13337
pubmed: 29802634
Yang CP, Liang CS, Chang CM, Yang CC, Shih PH, Yau YC, Tang KT, Wang SJ (2021) Comparison of new pharmacologic agents with triptans for treatment of migraine: a systematic review and meta-analysis. JAMA Netw Open 4(10):e2128544. https://doi.org/10.1001/jamanetworkopen.2021.28544
doi: 10.1001/jamanetworkopen.2021.28544
pubmed: 34633423
pmcid: 8506232
Croop R, Lipton RB, Kudrow D, Stock DA, Kamen L, Conway CM, Stock EG, Coric V, Goadsby PJ (2021) Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled trial. Lancet 97(10268):51–60. https://doi.org/10.1016/S0140-6736(20)32544-7
doi: 10.1016/S0140-6736(20)32544-7
Goadsby PJ, Dodick DW, Ailani J, Trugman JM, Finnegan M, Lu K, Szegedi A (2020) Safety, tolerability, and efficacy of orally administered atogepant for the prevention of episodic migraine in adults: a double-blind, randomised phase 2b/3 trial. Lancet Neurol 19(9):727–737. https://doi.org/10.1016/S1474-4422(20)30234-9
doi: 10.1016/S1474-4422(20)30234-9
pubmed: 32822633
Andrasik F, Grazzi L, D’Amico D, Sansone E, Leonardi M, Raggi A, Salgado-García F (2016) Mindfulness and headache: a “new” old treatment, with new findings. Cephalalgia 36(12):1192–1205. https://doi.org/10.1177/0333102416667023
doi: 10.1177/0333102416667023
pubmed: 27694139
Grazzi L, Raggi A, D’Amico D, Sansone E, Leonardi M, Andrasik F, Gucciardi A, Guido D, D’Andrea G (2019) A prospective pilot study of the effect on catecholamines of mindfulness training vs pharmacological prophylaxis in patients with chronic migraine and medication overuse headache. Cephalalgia 9(5):655–664. https://doi.org/10.1177/0333102418801584
doi: 10.1177/0333102418801584
Grazzi L, Sansone E, Raggi A, D’Amico D, De Giorgio A, Leonardi M, De Torres L, Salgado-García F, Andrasik F (2017) Mindfulness and pharmacological prophylaxis after withdrawal from medication overuse in patients with chronic migraine: an effectiveness trial with a one-year follow-up. J Headache Pain 18(1):15. https://doi.org/10.1186/s10194-017-0728-z
doi: 10.1186/s10194-017-0728-z
pubmed: 28161874
pmcid: 5292107
Wells R, O’Connell N, Pierce C, Estave P, Penzien DB, Loder E, Zeidan F, Houle TT (2021) Effectiveness of mindfulness meditation vs headache education for adults with migraine: a randomized clinical trial. JAMA Intern Med 181(3):317–328. https://doi.org/10.1001/jamainternmed.2020.7090
doi: 10.1001/jamainternmed.2020.7090
pubmed: 33315046
Grazzi l. Grignani E, Raggi A, Rizzoli P, Guastafierro E, (2021) Effect of a mindfulness-based intervention for chronic migraine and high frequency migraine in adolescents: a pilot single-arm open-label study. Int J Environ Res Public Health 18(22):11739. https://doi.org/10.3390/ijerph182211739
doi: 10.3390/ijerph182211739
Caponnetto V, Deodato M, Robotti M, Koutsokera M, Pozzilli V, Galati C, Nocera G, De Matteis E, De Vanna G, Fellini E, Halili G, Martinelli D, Nalli G, Serratore S, Tramacere I, Martelletti P, Raggi A; European Headache Federation School of Advanced Studies (EHF-SAS) (2021) Comorbidities of primary headache disorders: a literature review with meta-analysis. J Headache Pain 22(1):71. https://doi.org/10.1186/s10194-021-01281-z .
D’Amico D, Sansone E, Grazzi L, Giovannetti AM, Leonardi M, Schiavolin S, Raggi A (2018) Multimorbidity in patients with chronic migraine and medication overuse headache. Acta Neurol Scand 138(6):515–522. https://doi.org/10.1111/ane.13014
doi: 10.1111/ane.13014
pubmed: 30107027
Dresler T, Caratozzolo S, Guldolf K, Huhn JI, Loiacono C, Niiberg-Pikksööt T, Puma M, Sforza G, Tobia A, Ornello R, Serafini G; European Headache Federation School of Advanced Studies (EHF-SAS) (2019) Understanding the nature of psychiatric comorbidity in migraine: a systematic review focused on interactions and treatment implications. J Headache Pain 20(1):51. https://doi.org/10.1186/s10194-019-0988-x
Chu HT, Liang CS, Lee JT, Yeh TC, Lee MS, Sung YF, Yang FC (2018) Associations between depression/anxiety and headache frequency in migraineurs: a cross-sectional study. Headache 58(3):407–415. https://doi.org/10.1111/head.13215
doi: 10.1111/head.13215
pubmed: 29044546
Lantéri-Minet M, Radat F, Chautard MH, Lucas C (2005) Anxiety and depression associated with migraine: influence on migraine subjects’ disability and quality of life, and acute migraine management. Pain 118(3):319–326. https://doi.org/10.1016/j.pain.2005.09.010
doi: 10.1016/j.pain.2005.09.010
pubmed: 16289799
Sorbi MJ, Balk Y, Kleiboer AM, Couturier EG (2017) Follow-up over 20 months confirms gains of online behavioural training in frequent episodic migraine. Cephalalgia 37(3):236–250. https://doi.org/10.1177/0333102416657145
doi: 10.1177/0333102416657145
pubmed: 27558500
Bromberg J, Wood ME, Black RA, Surette DA, Zacharoff KL, Chiauzzi EJ (2012) A randomized trial of a web-based intervention to improve migraine self-management and coping. Headache 52(2):244–261. https://doi.org/10.1111/j.1526-4610.2011.02031.x
doi: 10.1111/j.1526-4610.2011.02031.x
pubmed: 22413151
pmcid: 3305283
Seng EK, Holroyd KA (2010) Dynamics of changes in self-efficacy and locus of control expectancies in the behavioral and drug treatment of severe migraine. Ann Behav Med 40(3):235–247. https://doi.org/10.1007/s12160-010-9223-3
doi: 10.1007/s12160-010-9223-3
pubmed: 20812037
Andrasik F, Flor H, Turk DC (2005) An expanded view of psychological aspects in head pain: the biopsychosocial model. Neurol Sci 26(Suppl 2):S87–S91. https://doi.org/10.1007/s10072-005-0416-7
doi: 10.1007/s10072-005-0416-7
pubmed: 15926029